1. Home
2. "This has the potential of being a blockbuster." Walsh said if regulators approve Avastin, it has a good chance of becoming a $1 billion-a-year seller for Genentech

"This has the potential of being a blockbuster." Walsh said if regulators approve Avastin, it has a good chance of becoming a $1 billion-a-year seller for Genentech